MET and metabolic dysfunction-associated steatotic liver disease: Among the most significantly downregulated genes in patients with NAFLD and cirrhosis was the MET proto-oncogene, a receptor tyrosine kinase with Hepatocyte Growth Factor (HGF) as ligand that is important for cellular survival and cellular migration, as well as invasion.